Glisoxepide

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Glisoxepide
Glisoxepide.svg
Glisoxepide molecule ball.png
Names
IUPAC name
N-[2-[4-(azepan-1-ylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-1,2-oxazole-3-carboxamide
Identifiers
3D model (JSmol)
ChemSpider
DrugBank
ECHA InfoCard 100.042.329
KEGG
UNII
Properties
C20H27N5O5S
Molar mass 449.52388 g/mol
Pharmacology
A10BB11 (WHO)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YesYN ?)
Infobox references

Glisoxepide (INN) is an orally available anti-diabetic drug from the group of sulfonylureas.[1] It belongs to second-generation sulfonylureas.[2]

References[edit]

  1. ^ Haupt E, Köberich W, Beyer J, Schöffling K (December 1971). "Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects". Diabetologia. 7 (6): 449–54. PMID 5004178. doi:10.1007/bf01212061. 
  2. ^ Loubatières, A; Ribes, G; Mariani, MM; Alric, R. "Pharmacological Comparison Between Tolbutamide and Two Second Generation Hypoglycemic Sulfonylureas (Glibenclamide and Glisoxepide)". Acta diabetologica latina. 10 (2): 261–82. PMID 4200420. doi:10.1007/bf02590661.